Keyphrases
Anchorage-independent Growth
8%
Birt-Hogg-Dubé Syndrome
9%
Birth Cohort
5%
BRCA mutation
36%
BRCA1, BRCA2
33%
BRCA2
91%
BRCA2 mutation
47%
BRCAness
6%
Breast
24%
Breast Cancer
46%
Breast Cancer Risk
39%
Breast Cancer Susceptibility Gene 1 (BRCA1)
78%
C-Myc
8%
Cancer Burden
21%
Cancer Registry
6%
Cancer Risk
26%
Carbohydrate Antigen 125 (CA125)
21%
Carcinoma Cell Lines
8%
Carrier Status
5%
Chromosome 3
26%
Clear Cell
21%
Clinical Features
21%
Clinical Genetic Services
21%
Clinical Genetics
25%
Cohort Effect
5%
Conventional Renal Cell Carcinoma
21%
CpG Island Methylation
21%
Cumulative Risk
5%
Danish Population
6%
Familial Breast Cancer
9%
Family History
13%
Family Risk
13%
Family Testing
5%
FBXW7
8%
First Degree
5%
First-degree Relatives
21%
FLCN Gene
8%
Genetic Features
6%
Genetic Services
5%
Genetic Testing
25%
Genotype-phenotype
21%
Germ Cells
27%
Germline mutation
27%
Head-and-neck
19%
High Risk
23%
High-risk Population
5%
Immunohistochemistry
9%
In Situ Hybridization
6%
Kaplan-Meier Analysis
8%
Kindred
19%
Large Families
5%
Late-onset
21%
Life Expectancy
21%
Lifetime Risk
12%
Methylation
8%
Methylation Analysis
27%
Moderate Risk
5%
Modifier Genes
21%
Mutation Analysis
21%
Mutation Carriers
39%
Neck Paragangliomas
19%
NHS Trusts
5%
Nonsyndromic
9%
Novel Genes
21%
Ovarian Cancer
89%
Ovarian Cancer Risk
12%
Ovarian Cancer Screening
5%
OVOL1
12%
Penetrance
28%
Phenocopy
21%
Pheochromocytoma
23%
Population Risk
21%
Population Survey
21%
Proband
8%
Proteotyping
21%
Renal Carcinoma Cells
8%
Renal Cell Carcinoma
100%
Renal Tumor
25%
Retrospective Audit
5%
Risk Group 4
5%
Risk Phenotypes
21%
SDHB mutation
21%
Second Analysis
5%
Segregation Analysis
21%
Service Setting
21%
Somatostatin
8%
Succinate Dehydrogenase B
21%
Succinate Dehydrogenase B mutation
12%
Translocation Carrier
21%
Transvaginal Ultrasound
21%
Tumor Genotyping
21%
Tumor Predisposition
21%
Tumor Risk
23%
Tumor Suppressor Gene
31%
Unaffected Relatives
5%
Von Hippel-Lindau
21%
Von Hippel-Lindau Disease
6%
With Woman
5%
Biochemistry, Genetics and Molecular Biology
Active Site
7%
Anchorage Independent Growth
11%
Autosomal Dominant Inheritance
10%
BRCA1
85%
BRCA2
90%
Cancer Genetics
21%
Cancer Incidence
5%
Cancer Registry
6%
Chromosome 3
9%
Chromosome 5
7%
Chromosome Translocation 3
34%
CpG Island
21%
Cysteine
7%
Cytogenetics
13%
F-Box Protein
7%
FBXW7
14%
Fluorescence in Situ Hybridization
5%
Fumarate Reductase
24%
Gene Deletion
7%
Genetic Screening
24%
Genetics
33%
Genotyping
21%
Germ Cell
42%
Germline
42%
Germline Mutation
30%
Life Expectancy
21%
Lifespan
6%
Mammalian Target of Rapamycin
7%
Messenger RNA
11%
Methylation
26%
Modifier Gene
21%
Oncogene C Myc
8%
Penetrance
34%
Phenocopy
21%
Proband
9%
Promoter Region
11%
Retrospective Study
7%
SDHB
42%
SDHD
6%
Somatostatin
8%
Succinate Dehydrogenase
24%
Tumor Suppressor Gene
32%
Ubiquitin-Conjugating Enzyme
14%
Von Hippel-Lindau Disease
21%